The Toronto Maple Leafs announced late on Sunday that alumnus Mark Kirton, who became a leading advocate in the fight against Amyotrophic Lateral Sclerosis (ALS), had passed away at age 67.

Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...

Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...

Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...

Former Leafs posted the news Sunday evening. Kirton, 67, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig’s ...